Ventas (VTR) Reports In-Line Q2 FFO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Ventas Reports 2016 Second Quarter Results
July 29, 2016 6:53 AM EDTContinued Strong Track Record of Earnings Growth Enhanced Companys Credit Profile Through Excellent Capital Markets Execution Announced $1.5 Billion Acquisition of Wexford Life Science and Medical Real Estate
CHICAGO--(BUSINESS WIRE)-- Ventas, Inc. (NYSE: VTR) (Ventas or the Company) today announced strong earnings on a healthy balance sheet for the second quarter of 2016, driven by excellent performance from the Companys high-quality healthcare and senior living properties and accretive acquisitions:
Income from continuing operations per diluted common share for... More
